Development of antimicrobial drug resistance in rectal Escherichia coli isolates from dogs hospitalized in an intensive care unit

Journal of the American Veterinary Medical Association

Volumn 229, Issue 5, 2006, Pages 694-699

  Ogeer Gyles, Jennifer ^a,b   Mathews, Karol A ^a   Sears, William ^a   Prescott, John F ^a   Weese, J S ^a   Boerlin, Patrick ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTIOFUR; CHLORAMPHENICOL; COTRIMOXAZOLE; ENROFLOXACIN; GENTAMICIN; NALIDIXIC ACID; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC SENSITIVITY DISK DIFFUSION TEST; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CORRELATION ANALYSIS; DOG; ESCHERICHIA COLI; HOSPITALIZATION; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; NON PARTICIPANT OBSERVATION; NONHUMAN; PROSPECTIVE STUDY; RECTUM; TEACHING HOSPITAL; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CROSS INFECTION; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALIZATION; MALE; MICROBIAL SENSITIVITY TESTS; RECTUM;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 33748545947     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.229.5.694     Document Type: Article

References (31)

1. Monnet DL, Archibald LK, Phillips L, et al. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modelling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance Systems Hospitals. Infect Control Hosp Epidemiol 1998;19:388-394.
2. Van den Bogaard AE, Stobbering EE, Epidemiology of resistance to antibiotics: links between animals and humans. Int J Antimicrob Agents 2000;14:327-335.
3. Friedland I, Stinson L, Ikaiddi M, et al. Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000. Infect Control Hosp Epidemiol 2003;24:607-612.
4. Houndt T, Ochman H. Long-term shifts in patterns of antibiotic resistance in enteric bacteria. Appl Environ Microbiol 2000;66:5406-5409.
5. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999;27:887-892.
6. Mateu E, Martin M. Why is antimicrobial resistance a veterinary problem as well? J Vet Med 2001;48:569-581.
7. Moss S, Frost AJ. The resistance to chemotherapeutic agents of Escherichia coli from domestic dogs and cats. Aust Vet J 1984;61:82-84.
8. De Graef EM. Antibiotic resistance among fecal indicator bacteria from healthy individually owned and kennel dogs. Microb Drug Resist 2004;10:65-69.
9. Harmonien J, Mentula S, Heikkila M, et al. Orally administered targeted recombinant beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance. Antimicrob Agents Chemother 2004;48:75-79.
10. Sannes MR, Kuskowski MA, Johnson JR. Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans. J Am Vet Med Assoc 2004;225:368-373.
11. Trott DJ, Filippich LJ, Bensink JC, et al. Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli. J Med Microbiol 2004;53:439-443.
12. Quinn PJ, Carter ME, Markey BK, et al. Enterobacteriaceae. In: Quinn PJ, Carter ME, Markey BK, et al, eds. Clinical veterinary microbiology. London: Mosby-Year Book Europe Ltd, Wolfe Publishing, 1994;209-236.
13. Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents. Document M31-A. Wayne, Pa: Clinical and Laboratory Standards Institute, 1999.
14. Performance standards for antimicrobial susceptibility testing; twelfth international supplement. Document M100-S12. Wayne, Pa: Clinical and Laboratory Standards Institute, 2002.
15. Vatapoulos AC, Kalapothaki V, Legakis NJ. Risk factors for nosocomial infections caused by gram-negative bacilli. The Hellenic Antibiotic Resistance Study Group.; Hosp Infect 1996;34:11-22.
16. Conly J. Antimicrobial resistance in Canada. Can Med Assoc J 2002;167:885-891.
17. Peres-Bota D, Rodriguez H, Dimopoulos G, et al. Are infections due to resistant pathogens associated with a worse outcome in critically ill patients? J infect 2003;47:307-316.
18. Monaghan C, Tierney U, Colleran E. Antibiotic resistance and R-factors in the fecal coliform flora of urban and rural dogs. Antimicrob Agents Chemother 1981;19:266-270.
19. Carattoli A, Lovari S, Franco A, et al. Extended-spectrum β-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 2005;49:833-835.
20. Oluoch AO, Kim CH, Weisiger RM, et al. Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998). J Am Vet Med Assoc 2001;218:381-384.
21. Hirsh DC, Jang SS. Antimicrobial susceptibility of selected infectious bacterial agents obtained from dogs. J Am Anim Hosp Assoc 1994;30:487-494.
22. Normand EH, Gibson NR, Taylor DJ, et al. Trends in antimicrobial resistance in bacterial isolates in a small animal referral hospital. Vet Rec 2000;146:151-155.
23. Feria C, Ferreira E, Correia JD, et al. Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J Antimicrob Chemother 2002;49:77-85.
24. Wise LA, Jones RL, Reif JS. Nosocomial canine urinary tract infections in a Veterinary teaching hospital (1983-1988). J Am Anim Hosp Assoc 1990;26:148-152.
25. Lanz R, Kuhnert P, Boerlin P. Antimicrobial resistance and resistance gene determinants in clinical Escherichia coli from different animal species in Switzerland. Vet Microbiol 2003;91:73-84.
26. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001;7:337-341.
27. Lindgren PK, Karlsson A, Hughes D. Mutation rates and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 2003;47:3222-3232.
28. Brinas L, Zarazaga M, Saenz Y, et al. β-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans and healthy animals. Antimicrob Agents Chemother 2002;46:3156-3163.
29. Poppe C, Martin LC, Gyles CL, et al. Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp enterica serovar Newport and Escherichia coli in the turkey poultry intestinal tract. Appl Environ Microbiol 2005;71:1184-1192.
30. Johnson TJ, Skyberg J, Nolan LK. Multiple antimicrobial resistance region of a putative virulence plasmid from an Escherichia coli isolate incriminated in avian colibacillosis. Avian Dis 2004;48:351-360.
31. Bischoff KM, White DG, Hume ME, et al. The chloramphenicol resistance gene cm1A is disseminated on transferable plasmids that confer multiple-drug resistance in swine Escherichia coli. FEMS Microbiol Lett 2005;243:285-291.